Sign in

Omer Dushek

@tcell.bsky.social
2.4K followers 415 following 58 posts

Professor of Molecular Immunology at the University of Oxford. Experiments & Math(s) to understand and exploit T cells. Founder & Director of MatchBio Ltd

PostsRepliesMedia
Reposted by Omer Dushek
Jun Allard @allardlab.bsky.social · 21/01/2026
Review article with Omer Dushek @tcell.bsky.social on tethered signaling proteins, out now! Tethered bio-molecular reactions can do at least 7 cool things that freely-diffusing reactions do not. Read more here! #IDR #TCells #cytoskeleton www.annualreviews.org/content/jour...
142
Reposted by Omer Dushek
The Dunn School, Oxford @dunnschool.bsky.social · 19/01/2026
A new study from the @tcell.bsky.social lab demonstrates a novel strategy to reduce dangerous off-target effects in engineered T cell therapies. Find out more: www.path.ox.ac.uk/news-article...
path.ox.ac.uk
Rewiring T cell co-receptors to improve the safety of cancer immunotherapy - Dunn School
A new study from the Dushek and van der Merwe labs demonstrates a novel strategy to reduce dangerous off-target effects in engineered T cell therapies.
073
Omer Dushek @tcell.bsky.social · 05/01/2026
🚀 Our new Publication in Nature Biomedical Engineering!🎉 📄 Title: Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors 🔗 Read the full paper here: www.nature.com/articles/s41...
nature.com
Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors - Nature Biomedical Engineering
This study shows that T cell cross-reactivity is influenced by the co-signalling molecules CD5, CD8 and CD4, and that cytotoxic T cells with a CD8→CD4 co-receptor switch show reduced cross-reactivity ...
1163
Omer Dushek @tcell.bsky.social · 27/11/2025
Our work accurately measuring the 3D affinity between the OT-I TCR and a large number of foreign and self antigen ligands is now published at EMBO Journal. Murine T-cell receptor OT-I exhibits imperfect discrimination between foreign and self-antigens www.embopress.org/doi/full/10....
embopress.org
Murine T-cell receptor OT-I exhibits imperfect discrimination between foreign and self-antigens | The EMBO Journal
imageimageThe OT-I mouse T-cell receptor (TCR) is thought to perfectly discriminate between lower-affinity self- and higher-affinity foreign antigen-MHC complexes. This study shows OT-I TCR to exhibit imperfect discrimination and to be activated ...
1114
Reposted by Omer Dushek
The EMBO Journal @embojournal.org · 27/11/2025
Murine T-cell receptor OT-I exhibits imperfect discrimination between foreign and self-antigens Omer Dushek @tcell.bsky.social and colleagues show that 3D solution affinities of the OT-I TCR for foreign and self-antigens predict functional T-cell responses www.embopress.org/doi/full/10....
153
Reposted by Omer Dushek
Malcolm Sim @mjwsim.bsky.social · 23/10/2025
UK NK 2026 in Cardiff. January 9th. Be there. eventbrite.co.uk/e/uk-nk-confer… Hosted by Rich Stanton, Ceri Fielding & Eddie Wang
eventbrite.co.uk
053
Reposted by Omer Dushek
Matthew Freeman @mjafreeman.bsky.social · 22/09/2025
I was Chair of @biologists.bsky.social when we started this initiative, the brainwave of the @stevenkelly.bsky.social It was an imaginative idea and I am thrilled to see this landmark Remember: @biologists.bsky.social are the goodies in scientific publishing!
0309
Reposted by Omer Dushek
Jun Allard @allardlab.bsky.social · 08/09/2025
We can make the flexibility of a model match the hypothesis being tested -- more flexibility is not always better, if it prohibits rejection of the hypothesis. Here is one simple case involving T cells where it made a difference! www.biorxiv.org/content/10.1...
051
Omer Dushek @tcell.bsky.social · 04/08/2025
If you're a postdoc interested in starting your own group, please consider the Dunn School at Oxford, UK. It's a fantastic department and university for molecular immunology and all aspects of immune research!
0105
Reposted by Omer Dushek
Immunotherapy Advances @imtadvances.bsky.social · 17/07/2025
Temporal control of cytokine production is lost in 2nd-gen CAR-T cells, says Patel et al. This could be key to understanding their efficacy and toxicity in cancer immunotherapy. 🧬 🔗 bit.ly/4lOLicw #CancerImmunotherapy
051
Omer Dushek @tcell.bsky.social · 31/05/2025
Our new review article led by Jordan Kramer: Platforms for studying cell–cell recognition by immune cells onlinelibrary.wiley.com/doi/10.1111/...
1186
Reposted by Omer Dushek
Dimova Lab @dimovalab.bsky.social · 09/05/2025
📢 Registration is open for the Biomembrane Days 2025! 🔗 biomembrane-days-2025.mpikg.mpg.de A top-notch lineup of speakers, 120 posters, 200 scientists. 📜Submit an abstract by July 14 🏆3 Poster prizes ⚠️Limited spots-previous events were fully booked! #BiomembraneDays2025 #Biophysics #CellMembranes
biomembrane-days-2025.mpikg.mpg.de
1228
Omer Dushek @tcell.bsky.social · 01/04/2025
CombiCells allow combinatorial display of cell surface ligands www.nature.com/articles/s41... A new Tools of the Trade article from Nature Reviews Immunology by Sofía Bustamante Eguiguren in our lab highlights the CombiCell platform to combinatorially display and titrate many cell surface ligands
173
Omer Dushek @tcell.bsky.social · 06/03/2025
The molecular reach of antibodies crucially underpins their viral neutralisation capacity Our work on measuring and understanding the role of molecular reach on antibody function is now part of a list of editor's pick manuscripts: www.nature.com/collections/...
nature.com
Microbiology and infectious diseases
This page highlights recent articles on all aspects of bacteriology, mycology, parasitology and virology, covering the biology of pathogens, host-pathogen ...
032
Omer Dushek @tcell.bsky.social · 22/02/2025
A fantastic EACR conference that focuses on all aspects of immune responses to cancer! Barcelona - May 2025
010
Reposted by Omer Dushek
Justin Eyquem @j-eyquem.bsky.social · 04/02/2025
🚨New paper alert! 🚨 Our latest work in @cp-immunity.bsky.social shows that Ark313, an evolved AAV variant enables in vivo genetic engineering of murine T cells! 🧵👇 sciencedirect.com/science/arti...
sciencedirect.com
In vivo engineering of murine T cells using the evolved adeno-associated virus variant Ark313
Genetic engineering of T cells in mouse models is essential for investigating immune mechanisms. We aimed to develop an approach to manipulate T cells…
54615
Reposted by Omer Dushek
British Society for Immunology @britsocimm.bsky.social · 06/02/2025
📢 LAST CHANCE to submit your abstracts for BSI Oxford and @immunologyoxford.bsky.social's #OIS25 Symposium This is your opportunity to take part in this celebration Oxford's outstanding #immunology research 🔬 Submissions are open until midnight on Friday 7th Feb 👉 bit.ly/4elJmnG
033
Reposted by Omer Dushek
British Society for Immunology @britsocimm.bsky.social · 30/01/2025
📢 Abstract submission for BSI Oxford and @immunologyoxford.bsky.social 's #OIS25 Symposium closes NEXT WEEK (7 Feb) Don't miss your chance to take part in this celebration of the outstanding #immunology research happening across Oxford 💫 Submit your abstract here 👉 bit.ly/4elJmnG
089
Reposted by Omer Dushek
ilesla.bsky.social @ilesla.bsky.social · 16/01/2025
Two weeks to go until the application deadline for ILESLA. If you or anyone you know would benefit from full funding to carry out a PhD in Life and/or Environmental Science please visit/refer to our website page iles.web.ox.ac.uk/how-apply where you can see open day videos and get full guidance.
iles.web.ox.ac.uk
How to Apply and Funding
12027
Reposted by Omer Dushek
The Dunn School, Oxford @dunnschool.bsky.social · 14/01/2025
We just can't stop recruiting! Associate professor in cell and molecular biology @dunnschool, with a preference for immunology, inflammation and/or infection - all defined broadly Come and be our colleague Deadline 28 Feb, please spread the word www.path.ox.ac.uk/vacancy/asso...
04859
Reposted by Omer Dushek
Gerard Lab @gerardlab.bsky.social · 16/01/2025
The OT-I TCR is often criticised as being very high-affinity and displaying unusual behaviour compared to other TCR transgenics. New work from @tcell.bsky.social shows this might not be the case. Will I still use OT-I and all the wonderful tools associated with it? Yes I will!
0123
Omer Dushek @tcell.bsky.social · 16/01/2025
Our new work! The 3D affinities of the OT-I TCR to foreign and self-antigens predict their 2D affinities and reveal imperfect antigen discrimination www.biorxiv.org/content/10.1...
1174
Reposted by Omer Dushek
The Dunn School, Oxford @dunnschool.bsky.social · 13/01/2025
A new paper by @tcell.bsky.social and team makes important advances towards improving CAR-T technology! Read the paper here: www.biorxiv.org/content/10.1... Listen to Omer talking about the paper and his spin-out company MatchBio here: podcasts.ox.ac.uk/series/immun...
044
Omer Dushek @tcell.bsky.social · 08/01/2025
Our new work on optimising CAR-T cell sensitivity is now on bioRxiv! Optimising CAR-T cell sensitivity by engineering matched extracellular sizes between CAR/antigen and CD2/CD58 adhesion complexes biorxiv.org/cgi/content/...
1287
Reposted by Omer Dushek
Adlung Lab @adlunglab.com · 07/01/2025
🧵 My former office mate and esteemed colleague Anna Huhn has co-authored a groundbreaking study in @naturecomms.bsky.social. 🦠 We're talking viruses and antibodies! 1/5
161
Omer Dushek @tcell.bsky.social · 04/01/2025
Our work led by Anna Huhn is now published! The molecular reach of antibodies crucially underpins their viral neutralisation capacity lnkd.in/epe8YZPm Thank you to the reviewers for constructive feedback!
184
Reposted by Omer Dushek
Waggoner Lab @labwaggoner.bsky.social · 03/01/2025
The molecular reach of antibodies crucially underpins their viral neutralization capacity www.nature.com/articles/s41... @naturecomms.bsky.social @tcell.bsky.social
061
Reposted by Omer Dushek
Adrian Liston @labliston.bsky.social · 19/12/2024
Pre-print time! This time our lab tackled the enigmatic "autoinflammation of unknown origin". This is a cluster of rare patients with #autoinflammatory disease, which don't fit the criteria of other syndromes. It's not even clear its a single #disease, to be honest www.biorxiv.org/content/10.1...
biorxiv.org
34713
Reposted by Omer Dushek
Rod Rahimi @rodrahimi.bsky.social · 29/11/2024
Friends, it's fun to see the #immunology community continue to grow! I created a 4th Starter Pack to help folks find each other. If you're an immunologist and you don't see yourself on the lists, let me know 🧪 go.bsky.app/PY5tCas go.bsky.app/FmERUoD go.bsky.app/6aT6qDS go.bsky.app/QSEPDoj
4012162
Reposted by Omer Dushek
Hanna Roetschke @hroetschke.bsky.social · 04/12/2024
📢 Only few more days left to submit an abstract for #INTERPHACE2025 at @thecrick.bsky.social or get an early-bird ticket! - deadline 13th Dec! Don't miss out on presenting your work in an interdisciplinary environment, network, or maybe even find new collaborators? tinyurl.com/5n94xcuw
053
Reposted by Omer Dushek
Nature Reviews Immunology @natrevimmunol.nature.com · 26/11/2024
The danger theory of immunity strikes back... rdcu.be/d1uQN
16225
Omer Dushek @tcell.bsky.social · 20/11/2024
Our new work! We show that T cell cross-reactivity can be reduced without modifying the TCR itself (by dramatically enhancing antigen discrimination). Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors www.biorxiv.org/content/10.1...
Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors
48523
Omer Dushek @tcell.bsky.social · 26/02/2024
Our new work! Regulation of temporal cytokine production by co-stimulation receptors in TCR-T cells is lost in CAR-T cells biorxiv.org/content/10.1... X Thread: x.com/Dushek/statu...
062
Reposted by Omer Dushek
Matthew Freeman @mjafreeman.bsky.social · 09/01/2024
Now this will be an interesting meeting... Pseudoenzymes are under-appreciated – but widespread and important meetings.embo.org/event/24-pse...
002
Omer Dushek @tcell.bsky.social · 04/01/2024
The key reagents from our recent CombiCell manuscript are now available on @addgene.bsky.social www.addgene.org/Omer_Dushek/ @embojournal www.embopress.org/doi/full/10....
addgene.org
Addgene: Omer Dushek Lab Materials
043
Reposted by Omer Dushek
The Dunn School, Oxford @dunnschool.bsky.social · 30/12/2023
We are thrilled to wake up to the news that Prof Liz Robertson CBE has been recognised in the New Year's Honours list She is now a Commander of the Order of the British Empire! Liz is a pioneer of mouse developmental genetics as well as an outstanding supporter of young scientists
0104
Omer Dushek @tcell.bsky.social · 21/12/2023
Our new work is now published in EMBO Journal! We describe a method for combinatorial display and titration of ligands directly on the surface of cells. We use it to study T-cell antigen sensitivity and the contribution of co-stimulation/inhibition receptors. www.embopress.org/doi/full/10....
086
Reposted by Omer Dushek
The Dunn School, Oxford @dunnschool.bsky.social · 27/11/2023
Hi 🇺🇸 Bluesky! Hope you had a great holiday. While you were giving thanks and eating, Oxford's Dunn School of Pathology decided it was time to set up here. Give us a follow for cutting edge biology underlying human disease, biomedical careers, research culture, students... www.path.ox.ac.uk
077
Reposted by Omer Dushek
Michael Hoffman @michaelhoffman.bsky.social · 24/11/2023
Canada to join Horizon Europe www.ctvnews.ca/canada/trude...
ctvnews.ca
Trudeau launches EU-Canada Summit in Newfoundland with research announcement
Prime Minister Justin Trudeau says Canada is joining the European Union's $100-billion scientific research program, called Horizon Europe.
04015
Reposted by Omer Dushek
Matthew Freeman @mjafreeman.bsky.social · 07/11/2023
The Dunn School at University of Oxford just can't stop recruiting! This time an Associate Prof in cell/mol biology with focus on infection, immunology, inflammation Come and join us... Please spread the word www.path.ox.ac.uk/vacancy/asso...
02337